GlassScriptPhysician profile
Muhammad Y Siddiq
NPI 1134140551
$14,409.58
in general payments reported to CMS, 2019-2025
49 companies · $1,622 in 2025
The $1,622 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,327 · 2020: $1,802 · 2021: $2,507 · 2022: $2,181 · 2023: $1,560 · 2024: $2,411 · 2025: $1,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,593.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,133.45 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Novartis Pharmaceuticals Corporation | $1,704.01 | 2019-2025 | |
| Abbvie INC. | $1,088.18 | 2021-2025 | Qulipta, Botox, Duopa |
| Sk Life Science, INC. | $1,019.50 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $811.33 | 2019-2024 | Qelbree |
| Genzyme Corporation | $747.69 | 2019-2025 | |
| Ucb, INC. | $640.36 | 2019-2025 | Rystiggo, Zilbrysq, Briviact |
| Genentech USA, INC. | $476.79 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Alexion Pharmaceuticals, INC. | $452.75 | 2019-2023 | Ultomiris |
| Janssen Pharmaceuticals, INC | $447.79 | 2020-2022 | |
| Allergan, INC. | $352.21 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $345.49 | 2019-2025 | Austedo Xr, Austedo |
| Emd Serono, INC. | $327.35 | 2019-2022 | |
| Mdd US Operations, LLC | $307.25 | 2024-2025 | Apokyn, Qelbree |
| Lilly USA, LLC | $280.06 | 2019-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Siddiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.